Literature DB >> 10428847

A role for the caveolin scaffolding domain in mediating the membrane attachment of caveolin-1. The caveolin scaffolding domain is both necessary and sufficient for membrane binding in vitro.

A Schlegel1, R B Schwab, P E Scherer, M P Lisanti.   

Abstract

Here, we have created a series of caveolin-1 (Cav-1) deletion mutants to examine whether the membrane spanning segment is required for membrane attachment of caveolin-1 in vivo. One mutant, Cav-1-(1-101), contains only the cytoplasmic N-terminal domain and lacks the membrane spanning domain and the C-terminal domain. Interestingly, Cav-1-(1-101) still behaves as an integral membrane protein but lacks any known signals for lipid modification. In striking contrast, another deletion mutant, Cav-1-(1-81), behaved as a soluble protein. These results implicate caveolin-1 residues 82-101 (also known as the caveolin scaffolding domain) in membrane attachment. In accordance with the postulated role of the caveolin-1 scaffolding domain as an inhibitor of signal transduction, Cav-1-(1-101) retained the ability to functionally inhibit signaling along the p42/44 mitogen-activated protein kinase cascade, whereas Cav-1-(1-81) was completely ineffective. To rule out the possibility that membrane attachment mediated by the caveolin scaffolding domain was indirect, we reconstituted the membrane binding of caveolin-1 in vitro. By using purified glutathione S-transferase-caveolin-1 fusion proteins and reconstituted lipid vesicles, we show that the caveolin-1 scaffolding domain and the C-terminal domain (residues 135-178) are both sufficient for membrane attachment in vitro. However, the putative membrane spanning domain (residues 102-134) did not show any physical association with membranes in this in vitro system. Taken together, our results provide strong evidence that the caveolin scaffolding domain contributes to the membrane attachment of caveolin-1.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10428847     DOI: 10.1074/jbc.274.32.22660

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  39 in total

Review 1.  Caveolins, liquid-ordered domains, and signal transduction.

Authors:  E J Smart; G A Graf; M A McNiven; W C Sessa; J A Engelman; P E Scherer; T Okamoto; M P Lisanti
Journal:  Mol Cell Biol       Date:  1999-11       Impact factor: 4.272

2.  Ligand-independent activation of oestrogen receptor alpha by caveolin-1.

Authors:  A Schlegel; C Wang; R G Pestell; M P Lisanti
Journal:  Biochem J       Date:  2001-10-01       Impact factor: 3.857

3.  The role of proline in the membrane re-entrant helix of caveolin-1.

Authors:  Satoko Aoki; Annick Thomas; Marc Decaffmeyer; Robert Brasseur; Richard M Epand
Journal:  J Biol Chem       Date:  2010-08-20       Impact factor: 5.157

4.  Interplay between Membrane Curvature and Cholesterol: Role of Palmitoylated Caveolin-1.

Authors:  Anjali Krishna; Durba Sengupta
Journal:  Biophys J       Date:  2018-12-01       Impact factor: 4.033

5.  A pH-Mediated Topological Switch within the N-Terminal Domain of Human Caveolin-3.

Authors:  Ji-Hun Kim; Jonathan P Schlebach; Zhenwei Lu; Dungeng Peng; Kaitlyn C Reasoner; Charles R Sanders
Journal:  Biophys J       Date:  2016-06-07       Impact factor: 4.033

6.  Cross-talk between Dopachrome Tautomerase and Caveolin-1 Is Melanoma Cell Phenotype-specific and Potentially Involved in Tumor Progression.

Authors:  Ioana L Popa; Adina L Milac; Livia E Sima; Petruta R Alexandru; Florin Pastrama; Cristian V A Munteanu; Gabriela Negroiu
Journal:  J Biol Chem       Date:  2016-04-06       Impact factor: 5.157

7.  Modulation of the caveolin-3 localization to caveolae and STAT3 to mitochondria by catecholamine-induced cardiac hypertrophy in H9c2 cardiomyoblasts.

Authors:  Kyuho Jeong; Hayeong Kwon; Chanhee Min; Yunbae Pak
Journal:  Exp Mol Med       Date:  2009-04-30       Impact factor: 8.718

Review 8.  Caveolin: a key target for modulating nitric oxide availability in health and disease.

Authors:  Bikramjit Dhillon; Mitesh V Badiwala; Shu-Hong Li; Ren-Ke Li; Richard D Weisel; Donald A G Mickle; Paul W M Fedak; Vivek Rao; Subodh Verma
Journal:  Mol Cell Biochem       Date:  2003-05       Impact factor: 3.396

9.  Role of Caveolin-1 in Indomethacin-induced Death of Human Hepatoadenocarcinoma SK-Hep1 Cells.

Authors:  Kyung-Nam Kim; Ju-Hee Kang; Sung-Vin Yim; Chang-Shin Park
Journal:  Korean J Physiol Pharmacol       Date:  2008-08-31       Impact factor: 2.016

Review 10.  Contributions of quantitative proteomics to understanding membrane microdomains.

Authors:  Yu Zi Zheng; Leonard J Foster
Journal:  J Lipid Res       Date:  2009-07-03       Impact factor: 5.922

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.